Amphastar Pharmaceuticals Inc (AMPH):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Amphastar Pharmaceuticals Inc (AMPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C10168)・商品コード:DATA904C10168
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:36
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Amphastar Pharmaceuticals Inc (Amphastar) is a specialty pharmaceutical company that develops, manufactures and markets generic and proprietary injectable, intranasal and inhalation products. It also sells insulin active pharmaceutical ingredient (insulin API) products. The company’s products includes enoxaparin sodium injection; cosyntropin for injection; naloxone hydrochloride (HCl) injection and phytonadione injection; ketorolac tromethamine injection; lidocaine HCl jelly 2%; amphadase hyaluronidase injection; lidocaine HCl 4% topical solution and Luer-Jet prefilled disposable syringes;. Amphastar’s offers its products to alternate care sites, hospitals, clinics and doctors’ offices and long-term care facilities. The company markets its products through subsidiaries, specialty distributors, wholesalers and retailers in the US, the UK, France and China. Amphastar is headquartered in Rancho Cucamonga, California, the US.

Amphastar Pharmaceuticals Inc (AMPH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Amphastar Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Amphastar Pharma Acquires 14 ANDAs from Hikma Pharma for USD4 Million 11
Amphastar Pharmaceuticals Acquires API manufacturing business of Merck 12
Equity Offering 13
Amphastar Pharma Raises USD40.8 Million in IPO 13
Asset Transactions 15
Athenex Acquires 14 ANDAs and Inventory for Certain APIs from Amphastar Pharma 15
Acquisition 16
Amphastar Pharma Acquires International Medication Systems from UCB Pharma for USD7.7 Million 16
Amphastar Nanjing Pharma Acquires Nanjing Letop Medical Technology USD1.7 Million 17
Amphastar Pharmaceuticals Inc – Key Competitors 18
Amphastar Pharmaceuticals Inc – Key Employees 19
Amphastar Pharmaceuticals Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Strategy And Business Planning 22
Jul 09, 2018: Amphastar Announces Expansion of Amphastar Nanjing Pharmaceuticals 22
Financial Announcements 23
Aug 08, 2018: Amphastar Pharmaceuticals reports financial results for the three months ended june 30, 2018 23
May 09, 2018: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2018 25
Mar 12, 2018: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2017 26
Nov 08, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2017 28
Aug 09, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2017 30
May 08, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2017 31
Mar 13, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2016 33
Legal and Regulatory 35
Mar 21, 2018: Amphastar Announces Final Judgment in the Patent Litigation against Momenta Pharmaceuticals and Sandoz 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amphastar Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Amphastar Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Amphastar Pharma Acquires 14 ANDAs from Hikma Pharma for USD4 Million 11
Amphastar Pharmaceuticals Acquires API manufacturing business of Merck 12
Amphastar Pharma Raises USD40.8 Million in IPO 13
Athenex Acquires 14 ANDAs and Inventory for Certain APIs from Amphastar Pharma 15
Amphastar Pharma Acquires International Medication Systems from UCB Pharma for USD7.7 Million 16
Amphastar Nanjing Pharma Acquires Nanjing Letop Medical Technology USD1.7 Million 17
Amphastar Pharmaceuticals Inc, Key Competitors 18
Amphastar Pharmaceuticals Inc, Key Employees 19
Amphastar Pharmaceuticals Inc, Other Locations 20
Amphastar Pharmaceuticals Inc, Subsidiaries 20

List of Figures
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Amphastar Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

★調査レポート[Amphastar Pharmaceuticals Inc (AMPH):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C10168)販売に関する免責事項を必ずご確認ください。
★調査レポート[Amphastar Pharmaceuticals Inc (AMPH):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆